Pryor Cashman Llp

Avg. Two Year Performance

No purchase track record
64% Avg. Sale Return
28% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(25%)5%(29%)(21%)64%
Sale Success Rate0 of 21 of 21 of 21 of 21 of 2

Adhera Therapeutics, Inc.

Drugs » Biotechnology

10% Owner:

Holdings: 1.59M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--